Recent Advances in the Use of Functional Foods: Effects of the Commercial Fermented Milk with Bifidobacterium Animalis Strain DN-173 010 and Yoghurt Strains on Gut Transit Time in the Elderly
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Fermented milk products containing the probiotic strain Bifidobacterium animalis DN-173 010 (BM) have a beneficial effect in reducing gut transit times in a range of populations including adults and the elderly, especially female. The aims of this study were to investigate the efficacy of one and two servings per day of BM in elderly subjects and to determine the duration of the reduction in transit times after stopping consumption of the product. This was a randomized controlled and open study with four groups; 200 elderly subjects (aged 50-75 years) were enrolled in the trial. In all, 100 subjects with medium transit times (MTT, 40-50 h) and 100 with slow transit times (STT, >50 h) were randomized to receive either 125 g or 250 g BM daily for 2 weeks. Oro-faecal gut transit was determined by the use of coloured markers. Both dosages significantly reduced oro-faecal transit time with reductions of 20.5% and 42.2% observed in MTT subjects receiving BM 125 g/day and 250 g/day, respectively ( p <0.0001). Corresponding reductions in STT subjects were 27.7% and 38.1%, respectively. The beneficial effects of BM lasted long after consumption of the product was stopped, with values returning to baseline in subjects with MTT at 6 weeks follow-up and in STT subjects consuming 125 g/day BM at 4 weeks follow-up. Significant differences in transit times were still observed at week 6 of follow-up in STT subjects receiving 250 g/day BM. This study completes and confirms the dose-dependent effects of BM from 0 to 250 g per day and can be compared with similar results obtained with 250 to 375g per day in a previous study on transit times in elderly subjects. It also demonstrates that there are significant beneficial effects long after consumption of the product has stopped. The results suggest an important role for this probiotic dairy product in fundamentally modulating gastrointestinal function that could beneficially affect the host, and hence reduce the susceptibility to conditions associated with delayed gut transit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In healthy adults as well as elderly subjects, a fermented milk containing Bifidobacterium animalis DN-173 010 alone or in association with the yoghurt starters Lactobacillus bulgaricus and Streptococcus thermophilus has been shown to decrease orofecal and ⁄ or colonic, especially sigmoid, transit time; [22][23][24][25]”
Citations
Cites
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Functional food science and gastrointestinal physiology and function
Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M.-C., Roberfroid, M., & Rowland, I. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980108 · Cited by 1,398
Fuller, R. (1991) · Gut · doi:10.1136/gut.32.4.439 · Cited by 862
Regulatory effects of bifidobacteria on the growth of other colonic bacteria
Gibson, G. R., & Wang, X. (1994) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1994.tb03443.x · Cited by 682 · cited 1×
“(31) reported that the effects of probiotics might be greater in subjects having initially slow transit times, and this has been confirmed in previous studies evaluating the effects of BM in people with transit times /40 h (26, 27).”
BackgroundEpidemiology of inflammatory bowel disease
Loftus, E. V., & Sandborn, W. J. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00002-4 · Cited by 542
The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
Goldin, B. R., & Gorbach, S. L. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.5.756 · Cited by 400 · cited 2×
“It is known that accelerated transit stimulates the growth and activity of the microflora (33).”
BackgroundMarteau, P., Cuillerier, E., Meance, S., Gerhardt, M. F., Myara, A., Bouvier, M., Bouley, C., Tondu, F., Bommelaer, G., & Grimaud, J. C. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01188.x · Cited by 254 · cited 3×
“These results were similar to those obtained in the previous study (26) investigating the dose-response effects of two and three servings of BM daily using the same protocol and methods.”
BackgroundResultEffect of the Normal Microbial Flora on Gastrointestinal Motility.
Abrams, G. D., & Bishop, J. E. (1967) · Experimental Biology and Medicine · doi:10.3181/00379727-126-32430 · Cited by 241 · cited 1×
“One proposed mechanism is that increasing the concentration of bifidobacteria in the gut may select microflora strains that are resistant to acid conditions, thus modifying the profile of gut microflora and its metabolites, such as short chain fatty acids, and consequently transit time (9, 10, 32, 33).”
BackgroundBifidobacterium from Fermented Milks: Survival During Gastric Transit
Berrada, N., Lemeland, J.-F., Laroche, G., Thouvenot, P., & Piaia, M. (1991) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(91)78183-6 · Cited by 203 · cited 1×
“These include good survival of the strain in the human gastrointestinal tract (17, 18, 21) and health benefits such as enhancement of the IgA antirotavirus responses and antimutagenic properties demonstrated in either animal or in vitro models (22 /24).”
BackgroundPochart, P., Marteau, P., Bouhnik, Y., Goderel, I., Bourlioux, P., & Rambaud, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.78 · Cited by 195 · cited 1×
“These include good survival of the strain in the human gastrointestinal tract (17, 18, 21) and health benefits such as enhancement of the IgA antirotavirus responses and antimutagenic properties demonstrated in either animal or in vitro models (22 /24).”
Background
Research works printed but not linked: 17
- McLean Baird I, 1977, Metabolism, 26, 28
- Eastwood MA, 1973, BMJ, 4, 5
- Sacquet E, 1970, CR Seances Soc Biol Fil, 164, 7
- Boriello SP, 1984, Scand J Gastroenterol, 19, 21
- Falk PG, 1998, Microbiol Mol Biol Rev, 62, 70
- Fuller R, 1989, J Appl Bacteriol, 66, 78
- Lee YK, 1995, Trends Food Sci Technol, 6, 5
- Fuller R, 1993, Int Food Ingred, 3, 6
- Tamine AY, 1995, J Dairy Res, 62, 87
- Moreau MC, 1998, Cambridge, 47, 51
- Abdelali H, 1995, Mut Res, 331, 41
- Meance S, 2001, Microb Ecol Health Dis, 13, 22
- Pathmakanthan S, 2000, Microb Ecol Health Dis, 30
- Cummings JH, 1997, Institute Danone Bruzelles, Belgium. Danone Chair Monograph, 2
- Imaizumi K, 2002, J Nutr Sci Vitaminol, 38, 51
- Meier R, 1993, J Parenter Nutr, 17, 5
- Hopper LV, 2001, Science, 291, 4
Cited by
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Leeming, E. R., Johnson, A. J., Spector, T. D., & Le Roy, C. I. (2019) · Nutrients · doi:10.3390/nu11122862 · Cited by 817
“On conclusion of the study, the reduced length of transit time observed only returned to baseline at 6-week follow-up for those with a medium transit time (40–50 h), and at 4-week follow-up for those with slow transit times (>50 h) who had been consuming 150 g of BM per day [54].”
BackgroundReview article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365
AGRAWAL, A., HOUGHTON, L. A., MORRIS, J., REILLY, B., GUYONNET, D., GOUPIL FEUILLERAT, N., SCHLUMBERGER, A., JAKOB, S., & WHORWELL, P. J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03853.x · Cited by 334
Metadata
- Authors
- Meance, S., Cayuela, C., Raimondi, A., Turchet, P., Lucas, C., & Antoine, J.-M.
- Affiliations
- Danone Vitapole FR-91767 Palaiseau Cedex
- Danone (France) (FR)
- ISERNT-ALPE ADRIA Trieste
- Venue
- Microbial Ecology in Health and Disease
- Publisher
- Informa UK Limited
- Published
- 2003-01
- Volume
- 15
- Issue
- 1
- Pages
- 15-22
- ISSN
- 0891-060X (ISSN-L)
- 1651-2235
- OpenAlex
- W4232130333
- Semantic Scholar
- 028109485bbbdaca28bbbff5aafe6581bf0cff64
- Cited by
- 44
- References
- 18
- Citations by year
- 2025: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 5
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Microbial Ecology in Health and Disease (publishedVersion, cc-by)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, fermented milk, yogurt, gut transit time, older adults, slow transit constipation, dose-dependent effects, gastrointestinal function, functional foods
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent Advances in the Use of Functional Foods: Effects of the Commercial Fermented Milk with Bifidobacterium Animalis Strain DN-173 010 and Yoghurt Strains on Gut Transit Time in the Elderly. https://app.cochat.ai/papers/10.1080/08910600310015565
- The paper
- Meance, S., Cayuela, C., Raimondi, A., Turchet, P., Lucas, C., & Antoine, J.-M. (2003). Recent Advances in the Use of Functional Foods: Effects of the Commercial Fermented Milk with Bifidobacterium Animalis Strain DN-173 010 and Yoghurt Strains on Gut Transit Time in the Elderly. Microbial Ecology in Health and Disease. https://doi.org/10.1080/08910600310015565
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.